lung cancer lung malignancy
Conditions
Interventions
Patients will be treated with 3-7 fractions of stereotactic radiotherapy
depending on the tumor location. Prior to treatment fiducials will be placed
using one of the following methods: bronchoscopy
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: The patient is eighteen years or older. The metastases are limited to a maximum of 2 organs, and one of the 2 is the lung. The patient has no more than 5 metastatic lesions. The primary tumor site is locally controlled. The interval between treatment of the primary tumor and diagnosis of the metastasis is at least four months. The patient has a life expectancy of at least 6 months.
Exclusion criteria
Exclusion criteria: Patients with more than 5 metastatic lesions. Patients with an active primary tumor site. pregnant women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Local control | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine whether treatment related toxicity is acceptable (maximal toxicity grade I-III). To determine prognostic factors on local control, overall survival and progression free survival. | — |
Countries
Netherlands
Outcome results
None listed